PMC:7029759 / 20182-20308
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"441","span":{"begin":62,"end":66},"obj":"Gene"},{"id":"442","span":{"begin":98,"end":102},"obj":"Gene"}],"attributes":[{"id":"A441","pred":"tao:has_database_id","subj":"441","obj":"Gene:652070"},{"id":"A442","pred":"tao:has_database_id","subj":"442","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T719","span":{"begin":18,"end":26},"obj":"GO:0042571"},{"id":"T718","span":{"begin":30,"end":36},"obj":"SO:0000984"},{"id":"T717","span":{"begin":43,"end":51},"obj":"GO:0042571"},{"id":"T716","span":{"begin":98,"end":102},"obj":"G_3;PG_10;PR:000003622"}],"text":"Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same."}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T114","span":{"begin":18,"end":26},"obj":"Body_part"},{"id":"T115","span":{"begin":43,"end":51},"obj":"Body_part"}],"attributes":[{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T128","span":{"begin":0,"end":126},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Alternatively, an antibody or single chain antibody fragment (scFv) could be administered against ACE2 to accomplish the same."}